Science Corp., a brain implant startup led by Neuralink co-founder Max Hodak, raised $230 million in Series C funding at a $1.5 billion valuation.
Why it matters: Science Corp. appears likely to bring the world's first computer-brain interface to market, initially in Europe, ahead of Neuralink or other rivals.
